A young case of kidney failure with thrombotic microangiopathy lesions in renal biopsy caused by accelerated hypertension

Japanese Journal of Nephrology

Volumn 51, Issue 7, 2009, Pages 878-883

  Higashi, Atsuko Y ^a   Nogaki, Fumiaki ^b   Ono, Takahiko ^c   Fukatsu, Atsushi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Shimada Municipal Hospital   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Accelerated hypertension; Renal biopsy; Thrombotic microangipathy

Indexed keywords

AMLODIPINE; CREATININE; RENIN; SPIRONOLACTONE; TEMOCAPRIL; TRICHLORMETHIAZIDE; VALPROIC ACID; VALSARTAN; VASOPRESSIN; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ESSENTIAL HYPERTENSION; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ARTERY STENOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MALIGNANT HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; THROMBOTIC THROMBOCYTOPENIC PURPURA; BIOPSY; DISEASE COURSE; HYPERTENSION; KIDNEY; PATHOLOGY; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BIOPSY; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE; MALE; PLATELET AGGREGATION INHIBITORS; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70549089766     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension : their course and prognosis. Am J Med Sci 1939 ; 197 : 332-343.
2. Volhard F, Fahr KT. Die Brightsche Nierenkrankeit. Berlin : Springer Verlag, 1914 : 247-280.
3. Kincaid-Smith P. Malignant hypertension. J Hypertens 1991 ; 9 : 893-899.
4. Ahmed M, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. BMJ 1986 ; 292 : 235-237. (Pubitemid 16161984)
5. Linton AL, Gavras H, Gleadle RI, Hutchison HE, Lauson DH, Lever AF, Macadam RF, McNichol GP, Robertson JIS. Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet 1969 ; 28 : 1277-1282.
6. Kincaid-Smith P. Malignant hypertension : mechanisms and management. Pharmac Ther 1980 ; 9 : 245-269.
7. Gravras H, Brown WCB, Brown JJ, Lever AF, Linton AF, Macadam RF, McNicol GP, Robertson JIS, Wardrop C. Microangiopathic hemolytic anaemia and the development of the malignant phase of hypertension. Circ Res 1971 ; 28(S11) : 127-141.
8. Gustafsson F. Hypertensive arteriolar necrosis revisited. Blood Press 1997 ; 6 : 71-77.
9. Beilin LJ, Goldby FS. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clin Sci Mol Med 1977 ; 52 : 111-117.
10. Ballermann J, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int 1998 ; 54(Suppl 67) : 100-108.
11. Robertson AL, Khairallah PA. Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res 1972 ; 31 : 923-931.
12. Fleming S. Malignant hypertension - the role of the paracrine renin-angiotensin system. J Pathol 2000 ; 192 : 135-139. (Pubitemid 30768977)
13. Petitti DB, Klatsky AL. Malignant hypertension in women aged 15 to 44 years and its relation to cigarette smoking and oral contraceptives. Am J Cardiol 1983 ; 52 : 297-298.
14. Hill GS. Studies on the pathogenesis of hypertensive vascular disease. Circ Res 1970 ; 27 : 657-668.
15. Chatelain RE, Bumpus FM, Chernicky CL, Ferrario CM. Differing patterns of altered glucocorticoid secretion in experimental malignant and benign hypertension. Influences upon the lymphoid system and on arterial connective tissue metabolism. J Pathol 1983 ; 139 : 69-88.
16. Gudbrandsson T, Hansson L, Helitz H, Lindholm L, Hicsson LA. Immunological changes in patients with previous malignant essential hypertension. Lancet 1981 ; 21 : 406-408. (Pubitemid 11188931)
17. Gavras H, Oliver N, Aitchison J, Begg C, Briggs JD, Brown JJ, Horton PW, Lee F, Lever AF, Prentice C, Robertson JIS. Abnormalities of coagulation and the development of malignant phase hypertension. Kidney Int 1975 ; 8 : S252-261.
18. Mohring J, Mohring B, Petri M, Haack D. Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney goldblatt hypertension. Circ Res 1978 ; 42 : 17-22. (Pubitemid 8264404)
19. Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) : Can we differentiate one from the other? Hypertens Res 2005 ; 28 : 89-95.